1/1
2 files

N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial

journal contribution
posted on 2022-07-13, 00:00 authored by J Sarris, G Byrne, D Castle, C Bousman, G Oliver, L Cribb, S Blair-West, V Brakoulias, D Camfield, C Ee, S Chamoli, M Boschen, Olivia DeanOlivia Dean, N Dowling, R Menon, J Murphy, N J Metri, T P Nguyen, A Wong, R Jordan, D Karamacoska, S L Rossell, Michael BerkMichael Berk, C H Ng
N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial

History

Journal

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volume

117

Article number

110550

Pagination

1 - 9

Publisher

Elsevier

Location

Amsterdam, The Netherlands

ISSN

0278-5846

eISSN

1878-4216

Language

eng

Publication classification

C1 Refereed article in a scholarly journal